Jessica Schneider

Jessica Schneider is Chief Scientific Officer, Corundum Systems Biology, she was previously a director at Takeda Ventures leading investment in NewCo builds for therapeutic modality platforms. Prior to this, she played a key role at Vedanta Biosciences developing the first live biotherapeutics product platform and a therapy for Clostridium difficile.

Posts by Jessica Schneider

MedCity Influencers

Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine

By aligning innovative scientific insights with strategic commercial pathways, the industry has the potential to fulfill its early promise – delivering safe, effective therapies that improve patient outcomes and create new opportunities for growth in the biopharmaceutical sector.

Jessica Schneider

Posts by Jessica Schneider

Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline

MedCity FemFwd: Inside Springboard Enterprises and Accenture’s New Women’s Health Report